Intrauterine Devices, Copper

Displaying 1 - 2 of 2CSV
Hofmeyr, G. J., Singata-Madliki, M., Batting, J., Steyn, P., Thomas, K. K., Issema, R., Beesham, I., Mbatsane, E., Morrison, C., Deese, J., Smit, J., Philip, N., Palanee-Phillips, T., Reddy, K., Onono, M., Mastro, T. D., & Baeten, J. M. (2024). Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLOS ONE, 19(5), e0299802. https://doi.org/10.1371/journal.pone.0299802
Publication Date
Mugo, N. R., Stalter, R. M., Heffron, R., Rees, H., Scoville, C. W., Morrison, C., Kourtis, A. P., Bukusi, E., Beksinska, M., Philip, N. M., Beesham, I., Deese, J., Edward, V., Donnell, D., Baeten, J. M., Baeten, J. M., Kiarie, J., Mastro, T. D., … Welch, J. D. (2021). Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. Clinical Infectious Diseases, 75(4), 586–595. https://doi.org/10.1093/cid/ciab1027
Publication Date